Woodward Diversified Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Buy |
9,011
+2,254
| +33% | +$418K | 0.85% | 27 |
|
|
2025
Q1 | $1.42M | Buy |
6,757
+267
| +4% | +$55.9K | 1% | 18 |
|
|
2024
Q4 | $1.15M | Sell |
6,490
-2,456
| -27% | -$436K | 0.85% | 24 |
|
|
2024
Q3 | $1.77M | Sell |
8,946
-211
| -2% | -$41.7K | 1.12% | 15 |
|
|
2024
Q2 | $1.57M | Buy |
9,157
+467
| +5% | +$80.1K | 0.92% | 24 |
|
|
2024
Q1 | $1.58M | Buy |
8,690
+515
| +6% | +$93.8K | 0.98% | 21 |
|
|
2023
Q4 | $1.27M | Sell |
8,175
-449
| -5% | -$69.6K | 0.8% | 26 |
|
|
2023
Q3 | $1.29M | Buy |
8,624
+668
| +8% | +$99.6K | 0.93% | 21 |
|
|
2023
Q2 | $1.07M | Buy |
7,956
+11
| +0.1% | +$1.48K | 0.81% | 35 |
|
|
2023
Q1 | $1.27M | Buy |
7,945
+111
| +1% | +$17.7K | 1% | 21 |
|
|
2022
Q4 | $1.27M | Sell |
7,834
-2,473
| -24% | -$400K | 1.02% | 21 |
|
|
2022
Q3 | $1.38M | Sell |
10,307
-368
| -3% | -$49.4K | 1.14% | 15 |
|
|
2022
Q2 | $1.64M | Buy |
10,675
+157
| +1% | +$24K | 1.25% | 18 |
|
|
2022
Q1 | $1.71M | Sell |
10,518
-3,736
| -26% | -$606K | 1.12% | 19 |
|
|
2021
Q4 | $1.93M | Buy |
14,254
+23
| +0.2% | +$3.11K | 1.14% | 16 |
|
|
2021
Q3 | $1.54M | Buy |
14,231
+356
| +3% | +$38.4K | 0.96% | 20 |
|
|
2021
Q2 | $1.56M | Sell |
13,875
-716
| -5% | -$80.7K | 0.89% | 22 |
|
|
2021
Q1 | $1.58M | Buy |
14,591
+4,103
| +39% | +$444K | 0.93% | 24 |
|
|
2020
Q4 | $1.12M | Buy |
+10,488
| New | +$1.12M | 0.73% | 40 |
|